Dimensional Fund Advisors LP increased its holdings in shares of Xylem Inc (NYSE:XYL) by 0.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 979,882 shares of the industrial products company’s stock after purchasing an additional 2,280 shares during the period. Dimensional Fund Advisors LP owned 0.55% of Xylem worth $66,020,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in XYL. BlackRock Inc. increased its holdings in shares of Xylem by 0.6% in the 1st quarter. BlackRock Inc. now owns 14,219,306 shares of the industrial products company’s stock valued at $1,093,749,000 after purchasing an additional 89,246 shares in the last quarter. Parnassus Investments CA increased its holdings in Xylem by 1.2% during the 2nd quarter. Parnassus Investments CA now owns 6,171,524 shares of the industrial products company’s stock valued at $415,837,000 after acquiring an additional 74,982 shares in the last quarter. Janus Henderson Group PLC increased its holdings in Xylem by 38.1% during the 2nd quarter. Janus Henderson Group PLC now owns 3,189,273 shares of the industrial products company’s stock valued at $214,898,000 after acquiring an additional 880,125 shares in the last quarter. USS Investment Management Ltd increased its holdings in Xylem by 43.7% during the 2nd quarter. USS Investment Management Ltd now owns 2,615,320 shares of the industrial products company’s stock valued at $176,220,000 after acquiring an additional 795,628 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in Xylem by 5.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,006,332 shares of the industrial products company’s stock valued at $135,187,000 after acquiring an additional 109,516 shares in the last quarter. Institutional investors own 85.85% of the company’s stock.
XYL has been the subject of several recent research reports. Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating and set a $84.00 target price for the company in a report on Thursday, August 2nd. BMO Capital Markets raised their price target on shares of Xylem from $83.00 to $84.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 1st. Berenberg Bank began coverage on shares of Xylem in a research note on Wednesday, October 3rd. They set a “sell” rating and a $65.00 price target on the stock. Oppenheimer reaffirmed a “buy” rating on shares of Xylem in a research note on Tuesday, July 31st. Finally, Cowen reaffirmed a “buy” rating and set a $85.00 price target on shares of Xylem in a research note on Friday. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $82.08.
In other news, insider Paul A. Stellato sold 3,000 shares of Xylem stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $78.63, for a total transaction of $235,890.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Kairus Tarapore sold 18,800 shares of Xylem stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $75.17, for a total transaction of $1,413,196.00. Following the sale, the senior vice president now owns 31,580 shares in the company, valued at approximately $2,373,868.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,284 shares of company stock worth $3,839,982. 0.81% of the stock is currently owned by corporate insiders.
Shares of XYL traded up $0.73 during mid-day trading on Friday, hitting $69.77. The company had a trading volume of 1,885,515 shares, compared to its average volume of 1,099,460. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.02 and a current ratio of 1.43. Xylem Inc has a 1-year low of $62.24 and a 1-year high of $82.44. The stock has a market capitalization of $14.35 billion, a PE ratio of 29.07, a P/E/G ratio of 1.52 and a beta of 1.22.
Xylem (NYSE:XYL) last released its earnings results on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.02. Xylem had a net margin of 7.39% and a return on equity of 19.04%. The business had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.28 billion. During the same period last year, the company earned $0.59 earnings per share. The company’s quarterly revenue was up 13.1% on a year-over-year basis. As a group, sell-side analysts expect that Xylem Inc will post 2.91 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Thursday, November 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, October 31st. This represents a $0.84 dividend on an annualized basis and a yield of 1.20%. Xylem’s dividend payout ratio (DPR) is 35.00%.
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Further Reading: Average Daily Trade Volume Explained
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.